Albert D. Dyrness

Insider Reports History

Entity
Individual
Location
C/O Sonnet Biotherapeutics Holdings, Inc, 100 Overlook Center, Princeton, NJ
Signature
/s/ John Harry Cross III, power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Albert D. Dyrness:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sonnet BioTherapeutics Holdings, Inc. Director Common Stock 537 $376 $0.70 Dec 11, 2023 Direct

Insider Reports Filed by Albert D. Dyrness

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 11, 2023 1 $0 4 Dec 5, 2024 Director
SONN Sonnet BioTherapeutics Holdings, Inc. May 30, 2023 1 $10.9K 4 May 31, 2023 Director
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 14, 2022 1 $0 4 Dec 22, 2022 Director
SONN Sonnet BioTherapeutics Holdings, Inc. Dec 15, 2021 1 $0 4 Apr 8, 2022 Director